Haftungsausschluss: Diese Website bündelt öffentlich verfügbare Daten aus offiziellen Quellen wie FDA, ClinicalTrials.gov, PubMed und SEC EDGAR nur zur allgemeinen Information. Sie stellt keine medizinische Beratung, Diagnose, Behandlungsempfehlung oder Anlageberatung dar.

PubMed

Regulatory Aspects of Artificial Intelligence and Machine Learning.

PMID: 39260776 ·

L, i, r, o, n, , P, a, n, t, a, n, o, w, i, t, z, ;, , M, a, t, t, h, e, w, , H, a, n, n, a, ;, , J, o, s, h, u, a, , P, a, n, t, a, n, o, w, i, t, z, ;, , J, o, e, , L, e, n, n, e, r, z, ;, , W, a, l, t, e, r, , H, , H, e, n, r, i, c, k, s, ;, , P, e, t, e, r, , S, h, e, n, ;, , B, r, u, c, e, , Q, u, i, n, n, ;, , S, h, a, n, n, o, n, , B, e, n, n, e, t, ;, , H, o, o, m, a, n, , H, , R, a, s, h, i, d, i

ZeitschriftModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Jahr
PMID39260776

Zusammenfassung

In the realm of health care, numerous generative and nongenerative artificial intelligence and machine learning (AI-ML) tools have been developed and deployed. Simultaneously, manufacturers of medical devices are leveraging AI-ML. However, the adoption of AI in health care raises several concerns, including safety, security, ethical biases, accountability, trust, economic impact, and environmental effects. Effective regulation can mitigate some of these risks, promote fairness, establish standar

Offizielle Quelle

Auf PubMed ansehen →

Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.

↑